Get the Stockscreener App
0.5403
0.00%
+0.00
Exicure Inc stock is currently priced at $0.5403, with a 24-hour trading volume of 17,559.
It has seen a +0.00% increased in the last 24 hours and a -14.05% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.5384 pivot point. If it approaches the $0.5517 resistance level, significant changes may occur.
Previous Close:
$0.5403
Open:
$0.519
24h Volume:
17,559
Market Cap:
$4.50M
Revenue:
$28.83M
Net Income/Loss:
$3.07M
P/E Ratio:
0.3216
EPS:
1.68
Net Cash Flow:
$-21.95M
1W Performance:
-9.57%
1M Performance:
-14.05%
6M Performance:
-5.44%
1Y Performance:
-42.81%
1D Range:
$0.507
$0.5481
52W Range:
$0.3647
$1.50
Exicure Inc Stock (XCUR) Company Profile
Name
Exicure Inc
Sector
Industry
Phone
847 673 1700
Address
2430 North Halsted Street, Chicago, IL
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Dec-18-20 | Initiated | BMO Capital Markets | Outperform |
| Nov-20-19 | Initiated | Guggenheim | Buy |
Exicure Inc Stock (XCUR) Latest News
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Benzinga
Exicure Inc Stock (XCUR) Financials Data
Exicure Inc (XCUR) Revenue 2024
XCUR reported a revenue (TTM) of $28.83 million for the quarter ending December 31, 2022, a +6,068% rise year-over-year.
Exicure Inc (XCUR) Net Income 2024
XCUR net income (TTM) was $3.06 million for the quarter ending June 30, 2023, a +105.76% increase year-over-year.
Exicure Inc (XCUR) Cash Flow 2024
XCUR recorded a free cash flow (TTM) of -$21.95 million for the quarter ending June 30, 2023, a +29.60% increase year-over-year.
Exicure Inc (XCUR) Earnings per Share 2024
XCUR earnings per share (TTM) was $1.68 for the quarter ending June 30, 2023, a +110.31% growth year-over-year.
About Exicure Inc
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
3.55%
0.52%
Cap:
|
Volume (24h):